Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Filters applied. Clear all
. 2017 Sep 19;8:228.
doi: 10.3389/fendo.2017.00228. eCollection 2017.

Exercise After You Eat: Hitting the Postprandial Glucose Target

Free PMC article

Exercise After You Eat: Hitting the Postprandial Glucose Target

Melissa L Erickson et al. Front Endocrinol (Lausanne). .
Free PMC article


We discuss a novel hypothesis: the effect size of postmeal exercise for attenuating postprandial glucose will be a function of the exercise bout vs. the size of the postprandial glucose response, specifically peak and duration of the postprandial glucose excursion.

Keywords: continuous glucose monitoring; glycemic control; postmeal exercise; postprandial glucose; type 2 diabetes.


Figure 1
Figure 1
Continuous glucose monitoring data during the postprandial phase of both sedentary and postmeal exercise conditions after a standardized meal in the same individual. Figure has been adapted from previously published works (20). American Physiological Society, permissions for reuse not required due to original authorship.
Figure 2
Figure 2
Indicates optimal range of postprandial glucose control. The upper glucose bound is set by the International Diabetes Federation Guidelines, while the lower glucose bound is defined by hypoglycemic risk. Continuous glucose monitoring data are representative of a 24-h glucose profile of an individual with type 2 diabetes. Summary data have been published previously (23).
Figure 3
Figure 3
Theoretical depiction. Solid line represents sedentary condition and dashed line represents postmeal exercise condition. (A) Displays larger effect size for postmeal exercise-induced glucose reduction in a smaller, shorter excursion. (B) Displays smaller effect size for a higher, longer glucose excursion.

Similar articles

See all similar articles


    1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med (1993) 329(14):977–86.10.1056/nejm199309303291401 - DOI - PubMed
    1. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (1998) 352(9131):837–53.10.1016/S0140-6736(98)07019-6 - DOI - PubMed
    1. Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA (1999) 281(21):2005–12.10.1001/jama.281.21.2005 - DOI - PubMed
    1. DeFronzo RA. Current issues in the treatment of type 2 diabetes. Overview of newer agents: where treatment is going. Am J Med (2010) 123(3 Suppl):S38–48.10.1016/j.amjmed.2009.12.008 - DOI - PubMed
    1. Jackson CA, Yudkin JS, Forrest RD. A comparison of the relationships of the glucose tolerance test and the glycated haemoglobin assay with diabetic vascular disease in the community. The Islington Diabetes Survey. Diabetes Res Clin Pract (1992) 17(2):111–23.10.1016/0168-8227(92)90156-L - DOI - PubMed

LinkOut - more resources